Larvol Delta - Safety-and-Efficacy-of-IM21-Cart-Cells-in-Patients-With-Recurrent-or-Refractory-BCMA-Positive-Multiple-Myeloma

IM21 CART - Immunochina Pharma

http://clinicaltrials.gov/ct2/show/NCT03711864

Sep 30, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next